Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
PharmiWeb
12h
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Projected to Reach USD 28 Billion by 2033 at a 9.5% of CAGR
Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...
FiercePharma
14h
Fierce Pharma Asia—Astellas' first-in-class FDA nod; Otsuka's IgAN win; Samsung Bio's $1.2B contract
Astellas' first-in-class CLDN18.2 drug Vyloy has cleared the FDA. After a positive phase 3 readout, Otsuka is targeting an ...
pharmaphorum
18h
NICE backs two AIs for remote heart failure monitoring
Updated guidance from health technology assessment (HTA) agency NICE has concluded that Boston Scientific's HeartLogic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Grateful Dead bassist dies
DOJ reaches settlement
DNA tests identify skull
Kristy now Category 5
Apology for past US policy
Murder-for-hire plot arrest
ABC News icon Jarriel dies
Browns sue city of Cleveland
Madigan corruption trial
Hit w/ discrimination claims
Dismissal of charge upheld
AI firm sued over suicide
Strike kills 3 journalists
4 astronauts return to Earth
US mortgage rate climbs
Louisiana forces relocation
New student loan relief plan
Announces layoffs, jet sales
SC teen voting glitch
Recalls chicken products
Exonerated after 22 years
Seeks Jan. 6 case dismissal
MO AG to probe Google
USF basketball coach dies
E. coli infections rise to 75
CO ballots to be reexamined
Phones hacked by China?
Israel strikes back at Iran
Approves Iterum's treatment
Gaza peace talks to resume?
VA voter roll purge blocked
PA registration fraud probe
Related topics
Vyloy
United States
Food and Drug Administration
Feedback